phenylpropanolamine has been researched along with Urinary Incontinence in 188 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (6.38) | 18.7374 |
| 1990's | 19 (10.11) | 18.2507 |
| 2000's | 143 (76.06) | 29.6817 |
| 2010's | 14 (7.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angulo, JC; Blauwet, MB; Cambronero, J; Dorrepaal, C; Herschorn, S; Khullar, V; Martin, NE; Nitti, VW; Siddiqui, E; van Kerrebroeck, P | 1 |
| Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P | 1 |
| Donovan, CE; Gordon, JM; Kutzler, MA | 1 |
| Bu, SY; Cao, CX; Duan, X; Peng, CD; Wang, KJ; Wu, T | 1 |
| Athanasopoulos, A; Gibson, W; Goldman, H; Madersbacher, H; Newman, D; Spinks, J; Wagg, A; Wyndaele, JJ | 1 |
| Byron, JK; Phillips, GS; Stahl, MS; Taylor, KH | 1 |
| Guan, Z; Nitti, VW; Rackley, R; Rovner, ES; Wang, JT | 1 |
| Azaripour, A; Hajebrahimi, S; Sadeghi-Bazargani, H | 1 |
| Boulton, S | 1 |
| Iannazzo, S; Pradelli, L | 1 |
| Chung, DE; Te, AE | 1 |
| Cardozo, L; Dmochowski, R; Khullar, V | 1 |
| Bryan, MK; Hilas, O; Nguyen, MT | 1 |
| Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ | 1 |
| Claeys, S; Hamaide, A; Noël, S; Rustichelli, F | 1 |
| Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P | 1 |
| Kane, RL; Ramakrishnan, R; Sainfort, F; Shamliyan, T; Wyman, JF | 1 |
| Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL | 1 |
| Chen, HQ; Li, Y; Qi, L; Zeng, F; Zhang, XY | 1 |
| Newman, DK | 1 |
| Cheon, C; Chung, KH; Lau, J; Leung, HY; Liu, YS; Wong, HK; Yip, SK | 1 |
| Goepel, M; Krege, S; Michel, MC; Schneider, T | 1 |
| Appell, RA | 2 |
| Bacon, NJ; Oni, O; White, RA | 1 |
| Cafiero, M; Maloney, CM | 1 |
| Crocker, J; Reinberg, Y; Vandersteen, D; Wolpert, J | 1 |
| Dimpfl, T; Garely, A; Payne, C; Swift, S | 1 |
| Bägli, DJ; Bolduc, S; Farhat, W; Khoury, AE; McLorie, GA; Payton, J; Upadhyay, J | 1 |
| Hader, C; Keller, T; Welz-Barth, A | 1 |
| Alhasso, A; Glazener, CM; N'Dow, J; Pickard, R | 2 |
| Goepel, M | 2 |
| Ellsworth, P | 1 |
| Brubaker, L; Kreder, KJ; Mainprize, T | 1 |
| Elliott, DS; Richelson, E | 1 |
| Appell, RA; Diokno, AC; Dmochowski, RR; Gburek, BM; Kell, SH; Klimberg, IW; Sand, PK | 1 |
| Freeman, R; Hill, S; Millard, R; Slack, M; Sutherst, J | 1 |
| Bang, LM; Easthope, SE; Perry, CM | 1 |
| Arnold, S; Hubler, M; Jöchle, W; Piché, CA; Reichler, IM; Trigg, TE | 1 |
| Homma, Y; Kawabe, K; Lee, JG; Paick, JS | 1 |
| Heilman, KM; Tsao, JW | 1 |
| Reidenberg, M; Siegler, EL | 1 |
| Homma, Y; Uemura, S | 1 |
| Hill, S; Jonas, U; Khullar, V; Laval, KU; Schiøtz, HA; Versi, E | 1 |
| Homma, Y; Kawabe, K | 1 |
| Burrows, L; Garely, AD | 1 |
| Chancellor, MB; Kim, HW; Koh, JS; Lee, JY; Lee, SJ; Suh, HJ | 1 |
| Bard, RJ; Casey, AR; Ethans, KD; Nance, PW; Schryvers, OI | 1 |
| Rovner, ES | 2 |
| Dubois, D; Hughes, DA | 1 |
| Staudenmeier, J; Williams, SG | 1 |
| Sand, PK | 1 |
| Athanasopoulos, A; Barbalias, G; Giannitsas, K; Gyftopoulos, K; Nikiforidis, G; Perimenis, P | 1 |
| DuBeau, CE; Khullar, V; Versi, E | 1 |
| Becker, D; Forte, L; Herschorn, S; Miller, E; Thompson, M | 1 |
| Wagenlehner, FM | 1 |
| Cardozo, L; Coyne, KS; Versi, E | 1 |
| Akkaya, E; Akman, S; Baykara, M; Danisman, A; Guntekin, E; Kukul, E; Yucel, S | 1 |
| Chen, MF; Lin, LS; Song, J; Song, YF | 1 |
| Dmochowski, RR; Rosenberg, MT | 1 |
| Greenfield, SP | 1 |
| Borgstein, NG; Djurhuus, JC; Ellsworth, P; Nijman, RJ | 1 |
| Athanasopoulos, AA; Perimenis, PS | 1 |
| Altan-Yaycioglu, R; Aydin Akova, Y; Guvel, S; Ozkardes, H; Yaycioglu, O | 1 |
| Cellar, J; Green, J; Jewart, RD; Lu, CJ; Tune, LE | 1 |
| Wein, AJ | 2 |
| Homma, Y; Takei, M | 1 |
| de la Rosette, JJ; Michel, MC; Piro, M; Schneider, T | 1 |
| Brünjes, R; Halaska, M; Jünemann, KP; Mürtz, G; Nurkiewicz, W; Rittstein, T; Schnabel, F | 1 |
| Anderson, RU; Chu, FM; Dmochowski, RR; Lama, DJ; Sand, PK | 1 |
| Machado, C; Singh-Franco, D; Tuteja, S; Zapantis, A | 1 |
| Bolodeoku, J; Chapple, CR; Drogendijk, T; Martinez-Garcia, R; Selvaggi, L; Toozs-Hobson, P; Warnack, W; Wright, DM | 1 |
| Gray, M | 1 |
| Coyne, KS; Matza, LS; Thompson, CL | 1 |
| Ellis, G; Hay-Smith, J; Herbison, P; Morris, A | 1 |
| Armstrong, RB; Luber, KM; Peters, KM | 1 |
| Blume, S; Gu, A; Jumadilova, Z; Shaya, FT; Zyczynski, T | 1 |
| Bavendam, T; Darkow, T; Frytak, JR; Jumadilova, Z; Nitz, NM | 1 |
| Girase, P; Jumadilova, Z; Ollendorf, DA; Varadharajan, S | 1 |
| Jumadilova, Z; Perfetto, EM; Subedi, P | 1 |
| Bavendam, T; Garely, AD; Roberts, RG | 1 |
| Angelico, P; Guarneri, L; Leonardi, A; Sironi, G; Testa, R; Velasco, C | 1 |
| Akino, H; Aoki, Y; Miwa, Y; Oyama, N; Yokoyama, O; Yusup, A | 1 |
| Appell, RA; Davila, GW; Dmochowski, RR; Nitti, VW; Sanders, SW | 1 |
| Caro, I; Caro, JJ; El-Hadi, W; Getsios, D | 1 |
| Dmochowski, RR; Staskin, DR; Wein, AJ | 1 |
| Athanasopoulos, A; Perimenis, P | 1 |
| Kwong, YY; Lam, DS; Leung, DY | 1 |
| Jonas, U; Rackley, RR | 1 |
| Sussman, DO; Taylor, PH | 1 |
| Agarwal, A; Dhiraaj, S; Kapoor, R; Singhal, V; Tandon, M | 1 |
| Kripke, C | 1 |
| Chancellor, MB; De Miguel, F; Kim, Y; Masuda, H; Yoshimura, N | 1 |
| Abrams, P; De Koning Gans, HJ; Kaplan, S; Millard, R | 1 |
| Bunyavejchevin, S | 1 |
| MacDiarmid, SA; Staskin, DR | 1 |
| Moodie, P | 1 |
| Brenner, B; Rice, M | 1 |
| Appell, RA; McCrery, RJ; Smith, PP | 1 |
| Arya, M; John, J; Khan, MS; Patel, HR; Sahai, A; Singh, R | 1 |
| Akgoz, S; Balkan, E; Dogruyol, H; Kilic, N; Sen, N | 1 |
| Guan, Z; Rackley, R; Rovner, ES; Wang, JT; Weiss, JP | 1 |
| Abrams, P; Guan, Z; Herschorn, S; Kaplan, SA; Roehrborn, CG; Rovner, ES | 1 |
| Bavendam, T; Carlsson, M; Elinoff, V; Eyland, N; Glasser, DB; Roberts, R | 1 |
| Aguilar, Y; Horstmann, M; Schaefer, T; Sievert, KD; Stenzl, A | 1 |
| Ayers, A; O'Sullivan, DM; Tulikangas, PK | 1 |
| Dmochowski, R; Guan, Z; Kaplan, SA; Roehrborn, CG; Rovner, ES; Wang, JT | 1 |
| Bavendam, T; Coyne, KS; Jumadilova, Z; Matza, LS; Thompson, C | 1 |
| Beck, E; Burkart, M; Goepel, M; Michel, MC; Oelke, M | 1 |
| Guan, Z; Khullar, V; Wang, JT; Wein, AJ | 1 |
| Alberca, R; Barrero, R; Campoy, P; Cayuela, A; Mir, P; Pena, JM | 1 |
| Armstrong, RB; Dmochowski, RR; Macdiarmid, S; Sand, PK | 1 |
| Carlsson, M; Dmochowski, R; Guan, Z; Kreder, K; MacDiarmid, S | 1 |
| Brodsky, M; Chapple, C; Forst, HT; Haag-Molkenteller, C; Massow, U; Tubaro, A; Van Kerrebroeck, P; Wang, J | 1 |
| Arnold, S; Burgherr, T; Hubler, M; Hung, L; Reichler, I | 1 |
| Hockey, J | 1 |
| Roumeguère, T | 1 |
| Kuo, HC | 1 |
| Bolis, P; Cardozo, L; Cromi, A; Khullar, V; Salvatore, S; Serati, M; Uccella, S | 1 |
| Kane, RL; Shamliyan, TA; Wilt, TJ; Wyman, J | 1 |
| Craig, B; Kritchevsky, S; Sands, LP; Sink, KM; Thomas, J; Xu, H | 1 |
| Ransley, PG; Rees, DL | 1 |
| Beisland, HO; Fossberg, E; Moer, A; Sander, S | 1 |
| Diokno, AC | 1 |
| Moen, M; Stien, R | 1 |
| Beisland, HO; Fossberg, E; Sander, S | 3 |
| Andersson, KE; Ek, A; Hedlund, H; Mattiasson, A | 1 |
| Lane, IF; Lappin, MR; Seim, HB | 1 |
| Hanzlick, R | 1 |
| Blendinger, C; Blendinger, K; Bostedt, H | 1 |
| Aaron, A; Eggleton, K; Holt, PE; Power, C | 1 |
| Eyett-Burton, C | 1 |
| Holt, PE | 1 |
| Höfner, K; Holmdahl, TH; Jonas, U; Madersbacher, H | 1 |
| Arnold, S | 1 |
| Balfour, JA; Hills, CJ; Winter, SA | 1 |
| Clarke, B; Davis, BE; Dwyer, P; Millard, R; Moore, K; Susset, J; Tuttle, J | 1 |
| Guay, DR | 1 |
| Kirchberger, I; Kobelt, G; Malone-Lee, J | 1 |
| Baines, SJ; Cheeseman, MT; Speakman, AJ; Williams, JM | 1 |
| Atan, A; Chancellor, MB; Erickson, JR; Kim, DY; Konety, BR; Yokoyama, T | 1 |
| Short, DD | 1 |
| Morgenstern, NE; Ruscin, JM | 1 |
| Appell, RA; Drutz, HP; Gleason, D; Klimberg, I; Radomski, S | 1 |
| Chapple, CR | 1 |
| Anderson, MJ; Benson, SR; Guay, DR; Lawrence, M | 1 |
| Scott, L | 1 |
| Arikian, SR; Casciano, J; Casciano, RN; Doyle, JJ; Tarride, JE | 1 |
| Appell, RA; Dmochowski, RR | 1 |
| Munding, M; Riden, D; Thornberry, B; Wessells, H | 1 |
| Mitova, E | 1 |
| Jonas, U; Kreder, K; Van Kerrebroeck, P; Wein, A; Zinner, N | 1 |
| Lemack, GE | 1 |
| Hellström, AL; Hjälmås, K; Läckgren, G; Mogren, K; Stenberg, A | 1 |
| Malone-Lee, JG; Maugourd, MF; Walsh, JB | 1 |
| DuBeau, CE | 1 |
| Baker, K; Harvey, MA; Wells, GA | 1 |
| Hartnett, NM; Saver, BG | 1 |
| Rovner, ES; Wein, AJ | 2 |
| Jacquetin, B; Wyndaele, J | 1 |
| Hall, JA; Meyer, JW; Nelson, MA; Wagner, S; Williamson, T | 1 |
| Weiss, BD | 1 |
| Nelson, D; Rackley, R; Wein, A | 1 |
| Crandall, C | 1 |
| Bernard, L; Goeree, R; O'Brien, BJ; Rosner, A; Williamson, T | 1 |
| Slagle, M | 1 |
| Starr, CH | 1 |
| Keller, MJ; Krähenbühl, S; Schlienger, RG | 1 |
| Kosier, JH; Newton, M; Smith, D | 1 |
| Mattiasson, A; Stanton, SL; Zinner, NR | 1 |
| Choo, MS; Chung, DY; Hong, JY; Kwon, HY; Lee, JG; Lee, JY; Lee, KS; Lee, T | 1 |
| Burrows, LJ; Garely, AD | 1 |
| Amark, P; Beck, O | 1 |
| Pomeroy, CJ; White, RA | 1 |
| Jakobsen, H; Steven, K | 1 |
| Lehtonen, T; Lindell, O; Lindskog, M; Rannikko, S; Talja, M; Wuokko, E | 1 |
| Ling, GV; Richter, KP | 1 |
44 review(s) available for phenylpropanolamine and Urinary Incontinence
| Article | Year |
|---|---|
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Clinical Trials, Phase III as Topic; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urological Agents; Young Adult | 2013 |
The role of mirabegron in overactive bladder: a systematic review and meta-analysis.
Topics: Acetanilides; Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Odds Ratio; Phenylpropanolamine; Prospective Studies; Research Design; Software; Surveys and Questionnaires; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents | 2014 |
Tolterodine extended-release for overactive bladder.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Drug Administration Schedule; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2009 |
Mixed incontinence: current evidence and future perspectives.
Topics: Adrenergic Uptake Inhibitors; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Duloxetine Hydrochloride; Estrogens; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urinary Incontinence, Urge | 2010 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Comparative Effectiveness Research; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2012 |
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
The newer antimuscarinic drugs: bladder control with less dry mouth.
Topics: Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2002 |
Achieving bladder control. Treatment in the primary care setting.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Estrogen Replacement Therapy; Female; Humans; Mandelic Acids; Medical History Taking; Middle Aged; Muscarinic Antagonists; Nurse Practitioners; Nursing Assessment; Phenylpropanolamine; Physical Examination; Primary Health Care; Referral and Consultation; Toilet Training; Tolterodine Tartrate; United States; Urinary Incontinence | 2002 |
Adrenergic drugs for urinary incontinence in adults.
Topics: Adrenergic Agonists; Adult; Clenbuterol; Female; Humans; Midodrine; Phenylpropanolamine; Randomized Controlled Trials as Topic; Urinary Incontinence; Urinary Incontinence, Stress | 2003 |
Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.
Topics: Adult; Aged; Benzhydryl Compounds; Constipation; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Trospium chloride in the management of overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Biological Availability; Cresols; Female; Half-Life; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Randomized Controlled Trials as Topic; Receptors, Muscarinic; Tissue Distribution; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
Overactive bladder: evaluation and management in primary care.
Topics: Algorithms; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Imipramine; Mandelic Acids; Phenylpropanolamine; Primary Health Care; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |
Tolterodine for the treatment of overactive bladder: a review.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Trospium chloride for the treatment of overactive bladder with urge incontinence.
Topics: Aging; Area Under Curve; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Female; Humans; Liver Failure; Male; Mandelic Acids; Metabolic Clearance Rate; Nortropanes; Phenylpropanolamine; Randomized Controlled Trials as Topic; Renal Insufficiency; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Assessment and management of urinary incontinence.
Topics: Aged; Behavior Therapy; Benzhydryl Compounds; Cresols; Exercise Therapy; Female; Humans; Male; Mandelic Acids; Mass Screening; Medical History Taking; Middle Aged; Muscarinic Antagonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Pelvic Floor; Phenylpropanolamine; Physical Examination; Prevalence; Risk Factors; Tolterodine Tartrate; United States; Urinalysis; Urinary Incontinence; Urodynamics | 2005 |
Adrenergic drugs for urinary incontinence in adults.
Topics: Adrenergic Agonists; Adult; Clenbuterol; Female; Humans; Midodrine; Phenylpropanolamine; Randomized Controlled Trials as Topic; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.
Topics: Benzhydryl Compounds; Cost of Illness; Cresols; Female; Humans; Male; Mandelic Acids; Markov Chains; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
Anticholinergic drugs for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2006 |
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |
The emergence of new drugs for overactive bladder.
Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Algorithms; Animals; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Models, Animal; Phenylpropanolamine; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence | 2006 |
[A meta-analysis documenting the optimal tolerance profile of tolterodine].
Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2006 |
A meta-analysis comparing trials of antimuscarinic medications funded by industry or not.
Topics: Benzhydryl Compounds; Cresols; Drug Industry; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Research Support as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2006 |
Mixed urinary incontinence: continuing to confound?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Severity of Illness Index; Thiophenes; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urodynamics; Urologic Surgical Procedures | 2007 |
Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Collagen; Cresols; Duloxetine Hydrochloride; Electric Stimulation Therapy; Estrogen Replacement Therapy; Exercise Therapy; Female; Humans; Magnetics; Mandelic Acids; Pelvic Floor; Pessaries; Phenylpropanolamine; Randomized Controlled Trials as Topic; Thiophenes; Tolterodine Tartrate; Urinary Incontinence | 2008 |
[Urinary incontinence in castrated female dogs. 2. Therapy].
Topics: Animals; Dog Diseases; Dogs; Ephedrine; Estrogens; Female; Ovariectomy; Phenylpropanolamine; Sympathomimetics; Urethra; Urinary Incontinence | 1995 |
[Urinary incontinence in castrated bitches. 2. Diagnosis and treatment].
Topics: Adrenergic alpha-Agonists; Animals; Collagen; Diagnosis, Differential; Dog Diseases; Dogs; Ephedrine; Female; Ovariectomy; Phenylpropanolamine; Urinary Incontinence | 1997 |
Tolterodine.
Topics: Animals; Benzhydryl Compounds; Cholinergic Antagonists; Controlled Clinical Trials as Topic; Cresols; Half-Life; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 1998 |
Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Drug Evaluation; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 1999 |
Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine.
Topics: Adult; Aged; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 1999 |
Tolterodine use for symptoms of overactive bladder.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 1999 |
Muscarinic receptor antagonists in the treatment of overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Clinical Trials as Topic; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2000 |
A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.
Topics: Benzhydryl Compounds; Budgets; Cholinergic Antagonists; Cost of Illness; Cost-Benefit Analysis; Cresols; Drug Costs; Humans; Mandelic Acids; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2000 |
Advancements in pharmacologic management of the overactive bladder.
Topics: Adrenergic alpha-Antagonists; Aged; Animals; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Benzilates; Benzofurans; Calcium Channel Blockers; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Drug Administration Routes; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Muscle Relaxants, Central; Nortropanes; Phenylpropanolamine; Pyrrolidines; Tolterodine Tartrate; Urinary Incontinence | 2000 |
Overactive bladder: optimizing quality of care.
Topics: Aged; Algorithms; Behavior Therapy; Benzhydryl Compounds; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Quality Assurance, Health Care; Tolterodine Tartrate; United States; Urinary Incontinence | 2001 |
Urinary incontinence management: new questions from old assumptions.
Topics: Age Factors; Aged; Benzhydryl Compounds; Cresols; Frail Elderly; Humans; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Research Design; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2001 |
Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2001 |
Tolterodine: a clinical review.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2001 |
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence | 2002 |
Current pharmacotherapeutic strategies for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 2002 |
59 trial(s) available for phenylpropanolamine and Urinary Incontinence
| Article | Year |
|---|---|
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2008 |
Tolterodine immediate release improves sexual function in women with overactive bladder.
Topics: Adult; Arousal; Benzhydryl Compounds; Cresols; Female; Humans; Libido; Middle Aged; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Quality of Life; Sexual Behavior; Sexual Dysfunction, Physiological; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence; Young Adult | 2008 |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2010 |
Comparative study of pelvic floor biofeedback training and tolterodine for treatment of detrusor after-contraction in posturination dribbling in children.
Topics: Adolescent; Benzhydryl Compounds; Biofeedback, Psychology; Child; Cresols; Female; Humans; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Pelvic Floor; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2012 |
A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder.
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Agonists; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2002 |
Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Dosage Forms; Female; Humans; Male; Mandelic Acids; Phenylpropanolamine; Retrospective Studies; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2003 |
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder.
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2003 |
[Therapy of mixed urinary incontinence].
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Germany; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urodynamics | 2003 |
Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urination | 2003 |
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Topics: Administration, Oral; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Diarrhea; Double-Blind Method; Female; Headache; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Salivation; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Tract Infections; Urination | 2003 |
Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Confidence Intervals; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Odds Ratio; Patient Satisfaction; Phenylpropanolamine; Probability; Reference Values; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders | 2003 |
Transdermal oxybutynin: for overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Exanthema; Humans; Mandelic Acids; Middle Aged; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2003 |
Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence; Urination | 2003 |
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Patient Acceptance of Health Care; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urination; Xerostomia | 2004 |
Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Humans; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Spinal Cord Injuries; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Xerostomia | 2004 |
Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Cross-Over Studies; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2004 |
"Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Medical Records; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
Impact of a health education intervention in overactive bladder patients.
Topics: Aged; Behavior Therapy; Benzhydryl Compounds; Cresols; Female; Humans; Life Style; Male; Middle Aged; Muscarinic Antagonists; Patient Compliance; Patient Education as Topic; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Validation of the urgency perception scale.
Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Perception; Phenylpropanolamine; Quality of Life; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
[A clinical study of pelvic floor electrical stimulation in treatment of overactive bladder].
Topics: Adult; Aged; Benzhydryl Compounds; Constipation; Cresols; Electric Stimulation Therapy; Female; Humans; Middle Aged; Pelvic Floor; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination; Urination Disorders; Xerostomia | 2004 |
Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
Topics: Benzhydryl Compounds; Body Weight; Child; Child, Preschool; Circadian Rhythm; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Placebo Effect; Placebos; Safety; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Incontinence; Urination | 2005 |
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
Topics: Accommodation, Ocular; Adult; Benzhydryl Compounds; Cresols; Eye Diseases; Humans; Intraocular Pressure; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Pupil; Single-Blind Method; Tears; Tolterodine Tartrate; Urinary Incontinence; Visual Acuity | 2005 |
Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Safety; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urodynamics | 2005 |
Propiverine versus tolterodine: efficacy and tolerability in patients with overactive bladder.
Topics: Adult; Benzhydryl Compounds; Benzilates; Calcium Channel Blockers; Cresols; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Incontinence | 2005 |
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2005 |
Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
Topics: Adult; Anti-Infective Agents, Urinary; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Intraoperative Care; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nephrostomy, Percutaneous; Phenylpropanolamine; Postoperative Complications; Prospective Studies; Severity of Illness Index; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Catheterization; Urinary Incontinence | 2006 |
Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence | 2006 |
Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
Topics: Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Incontinence | 2006 |
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 2006 |
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2006 |
Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.
Topics: Adolescent; Adult; Benzhydryl Compounds; Benzilates; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Hypertonia; Nortropanes; Parasympatholytics; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 2006 |
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 2006 |
Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.
Topics: Adult; Behavior Therapy; Benzhydryl Compounds; Cresols; Exercise Therapy; Female; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2007 |
The responsiveness of the OAB-q among OAB patient subgroups.
Topics: Adaptation, Psychological; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Agonists; Phenylpropanolamine; Sex Characteristics; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2007 |
Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cluster Analysis; Cresols; Delayed-Action Preparations; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Patient Satisfaction; Phenylpropanolamine; Principal Component Analysis; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2007 |
Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2007 |
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2007 |
The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2007 |
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Selection; Phenylpropanolamine; Safety; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2007 |
[Efficacy, tolerance and acceptability of Incontex in spayed bitches with urinary incontinence].
Topics: Adrenergic alpha-Agonists; Animals; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ovariectomy; Phenylpropanolamine; Safety; Treatment Outcome; Urinary Incontinence | 2007 |
Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation.
Topics: Aged; Drug Evaluation; Drug Therapy, Combination; Estriol; Female; Humans; Male; Menopause; Middle Aged; Phenylpropanolamine; Random Allocation; Urethra; Urinary Incontinence; Urodynamics | 1984 |
Sensory urgency in females: treatment with phenylpropanolamine.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenylpropanolamine; Pressure; Urethra; Urinary Incontinence | 1981 |
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urodynamics | 1997 |
Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis.
Topics: Adult; Analysis of Variance; Benzhydryl Compounds; Chi-Square Distribution; Cholinergic Antagonists; Confidence Intervals; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Statistics, Nonparametric; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1997 |
Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 1999 |
Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-up.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Surveys and Questionnaires; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 1999 |
Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1999 |
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.
Topics: Administration, Oral; Adult; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders | 2001 |
The overactive bladder in children: a potential future indication for tolterodine.
Topics: Administration, Oral; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2001 |
Tolterodine: a safe and effective treatment for older patients with overactive bladder.
Topics: Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Safety; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination Disorders; Xerostomia | 2001 |
Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Belgium; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; France; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urination; Urine | 2001 |
Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2002 |
Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination | 2002 |
Effect of phenylpropanolamine on incontinence in children with neurogenic bladders. A double-blind crossover study.
Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Neural Tube Defects; Phenylpropanolamine; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 1992 |
Lack of effect of cholinergic blocking and alpha-adrenergic stimulation on nocturnal incontinence after ileocaecal bladder replacement. A controlled randomised study.
Topics: Aged; Cecum; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ileum; Mandelic Acids; Middle Aged; Parasympatholytics; Peristalsis; Phenylpropanolamine; Postoperative Complications; Random Allocation; Time; Urinary Diversion; Urinary Incontinence | 1989 |
The effect of phenylpropanolamine on female stress urinary incontinence.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Phenylpropanolamine; Random Allocation; Stress, Physiological; Urinary Incontinence | 1986 |
85 other study(ies) available for phenylpropanolamine and Urinary Incontinence
| Article | Year |
|---|---|
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
Gonadotropin-releasing hormone immunization for the treatment of urethral sphincter mechanism incompetence in ovariectomized bitches.
Topics: Animals; Dog Diseases; Dogs; Female; Gonadotropin-Releasing Hormone; Immunization; Immunotherapy; Ovariectomy; Phenylpropanolamine; Urinary Incontinence | 2014 |
Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Frail Elderly; Humans; Muscarinic Antagonists; Phenylpropanolamine; Urinary Bladder, Overactive; Urinary Incontinence | 2014 |
Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease.
Topics: Age Factors; Animals; Body Weight; Diethylstilbestrol; Dog Diseases; Dogs; Female; Ovariectomy; Phenylpropanolamine; Retrospective Studies; Urethral Diseases; Urinary Incontinence | 2017 |
Changes to package labelling of Propalin.
Topics: Animals; Dog Diseases; Dogs; Drug Dosage Calculations; Drug Labeling; Female; Phenylpropanolamine; Urinary Incontinence | 2009 |
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2009 |
Syndrome of inappropriate antidiuretic hormone associated with tolterodine therapy.
Topics: Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2010 |
Clinical evaluation of a single daily dose of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch.
Topics: Adrenergic alpha-Agonists; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Female; Phenylpropanolamine; Retrospective Studies; Treatment Outcome; Urinary Incontinence | 2011 |
New treatment options for overactive bladder and incontinence.
Topics: Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Geriatric Assessment; Geriatric Nursing; Humans; Mandelic Acids; Muscarinic Antagonists; Nurse's Role; Nursing Assessment; Nursing Homes; Phenylpropanolamine; Prevalence; Toilet Training; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2002 |
Does gender or age affect the efficacy and safety of tolterodine?
Topics: Age Factors; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Logistic Models; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Sex Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination Disorders | 2002 |
Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustained-release formulation of phenylpropanolamine hydrochloride.
Topics: Animals; Delayed-Action Preparations; Dog Diseases; Dogs; Female; Phenylpropanolamine; Treatment Outcome; Urinary Incontinence | 2002 |
The use of tolterodine in children after oxybutynin failure.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Cross-Over Studies; Enuresis; Female; Humans; Infant; Male; Mandelic Acids; Phenylpropanolamine; Prospective Studies; Tartrates; Tolterodine Tartrate; Treatment Failure; Urinary Incontinence | 2003 |
[Urinary incontinence--treatment].
Topics: Adrenergic Uptake Inhibitors; Behavior Therapy; Benzhydryl Compounds; Benzilates; Biofeedback, Psychology; Cholinergic Antagonists; Contraindications; Cresols; Deamino Arginine Vasopressin; Electric Stimulation Therapy; Female; Humans; Imipramine; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Physical Therapy Modalities; Renal Agents; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2003 |
RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
Topics: Benzhydryl Compounds; Child; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Dosage Forms; Humans; Mandelic Acids; Phenylpropanolamine; Research Design; Retrospective Studies; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2003 |
Advances in medical management of overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Salivation; Tolterodine Tartrate; Treatment Outcome; United States; Urinary Incontinence; Urination | 2003 |
The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs.
Topics: Animals; Buserelin; Dog Diseases; Dogs; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Leuprolide; Luteinizing Hormone; Ovariectomy; Phenylpropanolamine; Sympathomimetics; Triptorelin Pamoate; Urinary Incontinence | 2003 |
Transient memory impairment and hallucinations associated with tolterodine use.
Topics: Aged; Benzhydryl Compounds; Cresols; Female; Hallucinations; Humans; Memory Disorders; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2003 |
Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.
Topics: Aged; Benzhydryl Compounds; Cholinesterase Inhibitors; Cresols; Dementia; Donepezil; Drug Interactions; Drug Therapy, Combination; Female; Humans; Indans; Muscarinic Antagonists; Phenylpropanolamine; Piperidines; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Use of the short form of King's Health Questionnaire to measure quality of life in patients with an overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Reproducibility of Results; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2004 |
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Humans; Male; Middle Aged; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics | 2004 |
Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Delayed-Action Preparations; Drug Costs; Female; Humans; Male; Mandelic Acids; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2004 |
[Overactive bladder. New anticholinergic drug controls urinary urge].
Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2004 |
Hallucinations with tolterodine.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Diagnosis, Differential; Female; Hallucinations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2004 |
[Therapy of bladder weakness].
Topics: Adult; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Topics: Adolescent; Behavior Therapy; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Combined Modality Therapy; Cresols; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Tolterodine for the treatment of daytime incontinence in children.
Topics: Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Placebo Effect; Placebos; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2005 |
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Topics: Benzhydryl Compounds; Cresols; Doxazosin; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence | 2005 |
Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications.
Topics: Activities of Daily Living; Alzheimer Disease; Benzhydryl Compounds; Caregivers; Cholinergic Antagonists; Cognition Disorders; Cresols; Cross-Over Studies; Humans; Memory Disorders; Mental Disorders; Muscarinic Antagonists; Neuropsychological Tests; Phenylpropanolamine; Psychometrics; Single-Blind Method; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Incontinence; Wakefulness | 2005 |
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urodynamics | 2005 |
Mixed incontinence.
Topics: Adrenergic Uptake Inhibitors; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Duloxetine Hydrochloride; Female; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urodynamics | 2005 |
Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Observation; Phenylpropanolamine; Safety; Severity of Illness Index; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urodynamics | 2005 |
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
Topics: Benzhydryl Compounds; Central Nervous System; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence | 2005 |
The responsiveness of the Overactive Bladder Questionnaire (OAB-q).
Topics: Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
Persistence with overactive bladder pharmacotherapy in a Medicaid population.
Topics: Adolescent; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Medicaid; Middle Aged; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Female; Health Care Costs; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Selection Bias; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Insurance Coverage; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin.
Topics: Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Health Care Costs; Humans; Mandelic Acids; Models, Theoretical; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.
Topics: Adult; Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
Topics: Animals; Benzhydryl Compounds; Cresols; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Tolterodine Tartrate; Urinary Bladder; Urinary Catheterization; Urinary Incontinence; Urination | 2005 |
Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats.
Topics: Administration, Intravesical; Afferent Pathways; Analysis of Variance; Animals; Benzhydryl Compounds; Cresols; Disease Models, Animal; Female; Infusions, Intravenous; Muscarinic Antagonists; Nerve Fibers, Unmyelinated; Phenylpropanolamine; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Incontinence | 2005 |
Bladder-health diaries: an assessment of 3-day vs 7-day entries.
Topics: Benzhydryl Compounds; Chi-Square Distribution; Cresols; Humans; Mandelic Acids; Medical Records; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Time; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Incontinence | 2005 |
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
Topics: Accommodation, Ocular; Benzhydryl Compounds; Cresols; Eye Diseases; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |
Contemporary treatment options for overactive bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Exercise; Female; Humans; Life Style; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Sex Factors; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Topics: Administration, Intravesical; Analysis of Variance; Animals; Benzhydryl Compounds; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
Urinary symptoms and quality of life changes in Thai women with overactive bladder after tolterodine treatment.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quality of Life; Surveys and Questionnaires; Thailand; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
PHARMAC responds on tolterodine for overactive bladder.
Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Evaluation; Government Regulation; Humans; Muscarinic Antagonists; New Zealand; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Patients with overactive bladders deserve better.
Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Administration Schedule; Drug Evaluation; Government Regulation; Humans; Muscarinic Antagonists; New Zealand; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2006 |
[Less disability in daily activities].
Topics: Activities of Daily Living; Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Germany; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Muscle Hypertonia; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2005 |
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
[Urinary symptoms and urodynamic findings in Parkinson's disease].
Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2007 |
Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
Topics: Benzhydryl Compounds; Cresols; Female; Humans; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2008 |
Editorial comment on: Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
Topics: Benzhydryl Compounds; Cresols; Female; Humans; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2008 |
Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Orgasm; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Young Adult | 2008 |
Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Benzhydryl Compounds; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Cresols; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Homes for the Aged; Humans; Male; Mandelic Acids; Neuropsychological Tests; Nursing Homes; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2008 |
Eskornade in the treatment of diurnal incontinence in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Delayed-Action Preparations; Drug Combinations; Female; Humans; Male; Phenylpropanolamine; Piperidines; Quaternary Ammonium Compounds; Retrospective Studies; Urinary Incontinence | 1980 |
Practical approach to the management of urinary incontinence in the elderly.
Topics: Aged; Epinephrine; Female; Humans; Male; Parasympatholytics; Phenylpropanolamine; Physical Exertion; Urinary Incontinence; Urinary Incontinence, Stress | 1983 |
Urge incontinence.
Topics: Central Nervous System Diseases; Cystitis; Female; Genital Diseases, Female; Humans; Male; Phenylpropanolamine; Pressure; Urethra; Urethritis; Urinary Bladder; Urinary Bladder Diseases; Urinary Incontinence | 1982 |
Urinary incontinence in old age.
Topics: Aged; Anal Canal; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Pressure; Urethra; Urinary Bladder; Urinary Catheterization; Urinary Incontinence; Urinary Incontinence, Stress; Urinary Tract Infections; Urodynamics | 1982 |
Combined treatment with estriol and alpha-adrenergic stimulation in elderly female patients with urinary incontinence. A pilot study.
Topics: Aged; Drug Therapy, Combination; Estriol; Female; Humans; Middle Aged; Phenylpropanolamine; Pilot Projects; Urinary Incontinence | 1981 |
Effects of prazosin on isolated human urethra and in patients with lower motor neurons lesions.
Topics: Adolescent; Adult; Aged; Female; Humans; In Vitro Techniques; Male; Middle Aged; Motor Neurons; Norepinephrine; Phentolamine; Phenylpropanolamine; Prazosin; Quinazolines; Urethra; Urinary Bladder, Neurogenic; Urinary Incontinence | 1981 |
Evaluation of results of preoperative urodynamic measurements in nine dogs with ectopic ureters.
Topics: Animals; Congenital Abnormalities; Dog Diseases; Dogs; Female; Phenylpropanolamine; Pressure; Treatment Outcome; Ureter; Ureterostomy; Urethra; Urinary Bladder; Urinary Incontinence | 1995 |
National Association of Medical Examiners Pediatric Toxicology Registry. Report 2: Phenylpropanolamine update.
Topics: Adolescent; Child; Coroners and Medical Examiners; Humans; Phenylpropanolamine; Registries; Societies, Medical; Toxicology; Urinary Incontinence | 1993 |
Urethral sphincter mechanism incompetence in male dogs: a retrospective analysis of 54 cases.
Topics: Adrenergic Agents; Aging; Animals; Dog Diseases; Dogs; Estrogens; Incidence; Male; Methyltestosterone; Phenylpropanolamine; Radiography; Retrospective Studies; Risk Factors; Testosterone Congeners; Urethra; Urinary Bladder; Urinary Incontinence | 1996 |
Urinary incontinence in cats.
Topics: Adrenergic alpha-Agonists; Animals; Cat Diseases; Cats; Female; Phenylpropanolamine; Urethra; Urinary Incontinence | 1997 |
Urinary incontinence in cats.
Topics: Animals; Cat Diseases; Cats; Phenylpropanolamine; Sympathomimetics; Urinary Incontinence | 1997 |
Genitourinary dysplasia in a cat.
Topics: Animals; Cats; Female; Laparotomy; Phenylpropanolamine; Radiography, Abdominal; Sympathomimetics; Urethra; Urethral Diseases; Urinary Bladder; Urinary Incontinence; Vagina | 1999 |
Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity--a comment.
Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 1999 |
Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Drug Prescriptions; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Parasympatholytics; Pharmaceutical Services; Phenylpropanolamine; Retrospective Studies; Time Factors; Tolterodine Tartrate; Urinary Incontinence | 2000 |
Urinary incontinence in rabbits.
Topics: Adrenergic alpha-Agonists; Animals; Phenylpropanolamine; Rabbits; Urinary Incontinence; Veterinary Drugs | 2000 |
Use of tolterodine in children with dysfunctional voiding: an initial report.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Urinary Incontinence | 2001 |
[Detrusitol - a drug of choice in impaired function of the bladder and urinary incontinence].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2000 |
Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Prospective Studies; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2001 |
Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
Topics: Aged; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; United States; Urinary Incontinence | 2000 |
Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Comorbidity; Cost of Illness; Cresols; Female; Health Care Costs; Humans; Insurance Claim Reporting; Longitudinal Studies; Male; Managed Care Programs; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Retrospective Studies; Tolterodine Tartrate; United States; Urinary Incontinence | 2001 |
POEMS (patient-oriented evidence that matters) spark discussion.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Evidence-Based Medicine; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2001 |
Medical treatment of overactive bladder.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Statistics as Topic; Tolterodine Tartrate; Urinary Incontinence | 2001 |
Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspective.
Topics: Benzhydryl Compounds; Canada; Cost-Benefit Analysis; Cresols; Economics, Pharmaceutical; Humans; Mandelic Acids; Markov Chains; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence | 2001 |
Medication update.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Deamino Arginine Vasopressin; Humans; Imipramine; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Renal Agents; Tolterodine Tartrate; Urinary Incontinence | 2002 |
Treatment can lead to a long dry spell.
Topics: Behavior Therapy; Benzhydryl Compounds; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Physical Therapy Modalities; Tolterodine Tartrate; United States; Urinary Incontinence | 2002 |
Tolterodine-associated acute mixed liver injury.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Benzhydryl Compounds; Bilirubin; Cresols; Female; Fever; gamma-Glutamyltransferase; Humans; Liver Failure, Acute; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Transaminases; Urinary Incontinence | 2002 |
Treatments for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Male; Mandelic Acids; Phenylpropanolamine; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2000 |
Phenylpropanolamine: an alpha-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence.
Topics: Animals; Dog Diseases; Dogs; Female; Phenylpropanolamine; Urethra; Urinary Incontinence | 1989 |
Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence.
Topics: Animals; Dog Diseases; Dogs; Estrogens; Female; Humans; Male; Phenylpropanolamine; Pressure; Testosterone; Urethra; Urethral Diseases; Urinary Incontinence; Urodynamics | 1985 |